01 1Signa S.A. de C.V.
01 1BREXPIPRAZOLE
01 1Mexico
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-03
Pay. Date : 2019-02-15
DMF Number : 33560
Submission : 2019-03-11
Status : Active
Type : II
20
Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BREXPIPRAZOLE, with a corresponding US DMF Number 33560.
Remarkably, this DMF maintains an Active status since its submission on March 11, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 03, 2019, and payment made on February 15, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
